191 related articles for article (PubMed ID: 26769682)
1. Long-term outcomes of persistent disease and relapse in primary membranous nephropathy.
Kanigicherla DA; Short CD; Roberts SA; Hamilton P; Nikam M; Harris S; Brenchley PE; Venning MC
Nephrol Dial Transplant; 2016 Dec; 31(12):2108-2114. PubMed ID: 26769682
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes and predictors for ESRD and mortality in primary GN.
Chou YH; Lien YC; Hu FC; Lin WC; Kao CC; Lai CF; Chiang WC; Lin SL; Tsai TJ; Wu KD; Chen YM
Clin J Am Soc Nephrol; 2012 Sep; 7(9):1401-8. PubMed ID: 22798538
[TBL] [Abstract][Full Text] [Related]
4. Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy.
Chen X; Chen Y; Ding X; Zhou Y; Lv Y; Li D; Chen B; Chen T; Chen C
Ren Fail; 2019 Nov; 41(1):363-369. PubMed ID: 31057017
[TBL] [Abstract][Full Text] [Related]
5. Membranous Nephropathy: Quantifying Remission Duration on Outcome.
Cattran DC; Kim ED; Reich H; Hladunewich M; Kim SJ;
J Am Soc Nephrol; 2017 Mar; 28(3):995-1003. PubMed ID: 27756808
[TBL] [Abstract][Full Text] [Related]
6. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of Chinese patients with membranous lupus nephropathy.
Sun HO; Hu WX; Xie HL; Zhang HT; Chen HP; Zeng CH; Liu ZH; Li LS
Lupus; 2008 Jan; 17(1):56-61. PubMed ID: 18089685
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes for primary glomerulonephritis: New Zealand Glomerulonephritis Study.
Chembo CL; Marshall MR; Williams LC; Walker RJ; Lynn KL; Irvine J; Pilmore HL
Nephrology (Carlton); 2015 Dec; 20(12):899-907. PubMed ID: 26096749
[TBL] [Abstract][Full Text] [Related]
9. Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy.
Thompson A; Cattran DC; Blank M; Nachman PH
J Am Soc Nephrol; 2015 Dec; 26(12):2930-7. PubMed ID: 26078365
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of pathological features of primary membranous nephropathy.
Zhang XD; Cui Z; Zhang MF; Wang J; Zhang YM; Qu Z; Wang X; Huang J; Wang F; Meng LQ; Cheng XY; Wang SX; Liu G; Zhao MH
BMC Nephrol; 2018 Aug; 19(1):215. PubMed ID: 30153817
[TBL] [Abstract][Full Text] [Related]
11. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
12. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S
Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488
[TBL] [Abstract][Full Text] [Related]
13. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
14. Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases.
Wang R; Wang M; Xia Z; Gao C; Shi Z; Fang X; Wu H; Peng Y
J Nephrol; 2021 Apr; 34(2):589-596. PubMed ID: 32770523
[TBL] [Abstract][Full Text] [Related]
15. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
[TBL] [Abstract][Full Text] [Related]
16. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.
Obi Y; Kimura T; Nagasawa Y; Yamamoto R; Yasuda K; Sasaki K; Kitamura H; Imai E; Rakugi H; Isaka Y; Hayashi T
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1558-65. PubMed ID: 20558563
[TBL] [Abstract][Full Text] [Related]
17. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
Koo HS; Kim S; Chin HJ
Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
[TBL] [Abstract][Full Text] [Related]
18. Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up.
Albertazzi V; Fontana F; Giberti S; Aiello V; Battistoni S; Catapano F; Graziani R; Cimino S; Scichilone L; Forcellini S; De Fabritiis M; Sara S; Delsante M; Fiaccadori E; Mosconi G; Storari A; Mandreoli M; Bonucchi D; Buscaroli A; Mancini E; Rigotti A; La Manna G; Gregorini M; Donati G; Cappelli G; Scarpioni R;
J Nephrol; 2024 Mar; 37(2):471-482. PubMed ID: 37957455
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults.
Szeto CC; Lai FM; Chow KM; Kwan BC; Kwong VW; Leung CB; Li PK
Am J Kidney Dis; 2015 May; 65(5):710-8. PubMed ID: 25465164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
